HEADER GENE REGULATION 15-JUL-20 6ZS2 TITLE CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN TRANSCRIPTION ACTIVATOR TITLE 2 BRG1 (SMARCA4) IN COMPLEX WITH 2-(6-AMINO-5-(PIPERAZIN-1-YL) TITLE 3 PYRIDAZIN-3-YL)PHENOL COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRANSCRIPTION ACTIVATOR BRG1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ATP-DEPENDENT HELICASE SMARCA4,BRG1-ASSOCIATED FACTOR 190A, COMPND 5 BAF190A,MITOTIC GROWTH AND TRANSCRIPTION ACTIVATOR,PROTEIN BRG-1, COMPND 6 PROTEIN BRAHMA HOMOLOG 1,SNF2-BETA,SWI/SNF-RELATED MATRIX-ASSOCIATED COMPND 7 ACTIN-DEPENDENT REGULATOR OF CHROMATIN SUBFAMILY A MEMBER 4; COMPND 8 EC: 3.6.4.-; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SMARCA4, BAF190A, BRG1, SNF2B, SNF2L4; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS BROMODOMAIN, ATP-DEPENDENT HELICASE SMARCA4, BRG1-ASSOCIATED FACTOR KEYWDS 2 190A, BAF190A, MITOTIC GROWTH AND TRANSCRIPTION ACTIVATOR, PROTEIN KEYWDS 3 BRG-1, PROTEIN BRAHMA HOMOLOG 1, SNF2-BETA, SWI/SNF-RELATED MATRIX- KEYWDS 4 ASSOCIATED ACTIN-DEPENDENT REGULATOR OF CHROMATIN SUBFAMILY A MEMBER KEYWDS 5 4, STRUCTURAL GENOMICS CONSORTIUM, SGC, TRANSCRIPTION, GENE KEYWDS 6 REGULATION EXPDTA X-RAY DIFFRACTION AUTHOR F.PREUSS,A.C.JOERGER,A.KRAEMER,M.WANIOR,S.KNAPP,STRUCTURAL GENOMICS AUTHOR 2 CONSORTIUM (SGC) REVDAT 3 31-JAN-24 6ZS2 1 REMARK REVDAT 2 05-MAY-21 6ZS2 1 JRNL REVDAT 1 07-OCT-20 6ZS2 0 JRNL AUTH M.WANIOR,F.PREUSS,X.NI,A.KRAMER,S.MATHEA,T.GOBEL, JRNL AUTH 2 D.HEIDENREICH,S.SIMONYI,A.S.KAHNT,A.C.JOERGER,S.KNAPP JRNL TITL PAN-SMARCA/PB1 BROMODOMAIN INHIBITORS AND THEIR ROLE IN JRNL TITL 2 REGULATING ADIPOGENESIS. JRNL REF J.MED.CHEM. V. 63 14680 2020 JRNL REFN ISSN 0022-2623 JRNL PMID 33216538 JRNL DOI 10.1021/ACS.JMEDCHEM.0C01242 REMARK 2 REMARK 2 RESOLUTION. 1.57 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10.1_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.57 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.25 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 35224 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.181 REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : 0.215 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.943 REMARK 3 FREE R VALUE TEST SET COUNT : 1741 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 34.2487 - 3.5909 0.99 2828 154 0.1763 0.2070 REMARK 3 2 3.5909 - 2.8506 0.99 2789 150 0.1860 0.2337 REMARK 3 3 2.8506 - 2.4904 1.00 2769 162 0.1846 0.1981 REMARK 3 4 2.4904 - 2.2628 1.00 2803 144 0.1782 0.2171 REMARK 3 5 2.2628 - 2.1006 1.00 2793 145 0.1771 0.2204 REMARK 3 6 2.1006 - 1.9768 1.00 2766 155 0.1799 0.2593 REMARK 3 7 1.9768 - 1.8778 1.00 2803 126 0.1892 0.2152 REMARK 3 8 1.8778 - 1.7960 1.00 2780 151 0.1761 0.2275 REMARK 3 9 1.7960 - 1.7269 1.00 2792 144 0.1706 0.1784 REMARK 3 10 1.7269 - 1.6673 1.00 2794 130 0.1644 0.1907 REMARK 3 11 1.6673 - 1.6152 1.00 2799 139 0.1716 0.2106 REMARK 3 12 1.6152 - 1.5700 1.00 2767 141 0.1730 0.2017 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.142 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.185 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 12.13 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.32 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 2070 REMARK 3 ANGLE : 0.773 2792 REMARK 3 CHIRALITY : 0.046 310 REMARK 3 PLANARITY : 0.004 386 REMARK 3 DIHEDRAL : 15.670 1342 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6ZS2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-JUL-20. REMARK 100 THE DEPOSITION ID IS D_1292108248. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-MAY-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91842 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35278 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.570 REMARK 200 RESOLUTION RANGE LOW (A) : 47.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 6.200 REMARK 200 R MERGE (I) : 0.06100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.57 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.60 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.24600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5DKD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.31 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALLIZATION BUFFER: 20% MEDIUM REMARK 280 -MOLECULAR-WEIGHT PEG SMEAR, 0.1 M TRIS PH 8.5, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 32.45500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A1460 CD CE NZ REMARK 470 LYS A1471 CE NZ REMARK 470 LYS A1473 CD CE NZ REMARK 470 LYS A1492 CG CD CE NZ REMARK 470 ARG A1502 CD NE CZ NH1 NH2 REMARK 470 GLN A1562 CG CD OE1 NE2 REMARK 470 LYS A1563 CG CD CE NZ REMARK 470 LYS B1460 CD CE NZ REMARK 470 LYS B1527 CG CD CE NZ REMARK 470 GLN B1534 CD OE1 NE2 REMARK 470 GLN B1562 CG CD OE1 NE2 REMARK 470 LYS B1563 CD CE NZ REMARK 470 LYS B1566 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A1452 82.58 -151.12 REMARK 500 SER B1452 84.74 -150.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FX5 A 1601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 1602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FX5 B 1601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 1602 DBREF 6ZS2 A 1451 1569 UNP P51532 SMCA4_HUMAN 1418 1536 DBREF 6ZS2 B 1451 1569 UNP P51532 SMCA4_HUMAN 1418 1536 SEQADV 6ZS2 SER A 1449 UNP P51532 EXPRESSION TAG SEQADV 6ZS2 MET A 1450 UNP P51532 EXPRESSION TAG SEQADV 6ZS2 SER B 1449 UNP P51532 EXPRESSION TAG SEQADV 6ZS2 MET B 1450 UNP P51532 EXPRESSION TAG SEQRES 1 A 121 SER MET LEU SER PRO ASN PRO PRO ASN LEU THR LYS LYS SEQRES 2 A 121 MET LYS LYS ILE VAL ASP ALA VAL ILE LYS TYR LYS ASP SEQRES 3 A 121 SER SER SER GLY ARG GLN LEU SER GLU VAL PHE ILE GLN SEQRES 4 A 121 LEU PRO SER ARG LYS GLU LEU PRO GLU TYR TYR GLU LEU SEQRES 5 A 121 ILE ARG LYS PRO VAL ASP PHE LYS LYS ILE LYS GLU ARG SEQRES 6 A 121 ILE ARG ASN HIS LYS TYR ARG SER LEU ASN ASP LEU GLU SEQRES 7 A 121 LYS ASP VAL MET LEU LEU CYS GLN ASN ALA GLN THR PHE SEQRES 8 A 121 ASN LEU GLU GLY SER LEU ILE TYR GLU ASP SER ILE VAL SEQRES 9 A 121 LEU GLN SER VAL PHE THR SER VAL ARG GLN LYS ILE GLU SEQRES 10 A 121 LYS GLU ASP ASP SEQRES 1 B 121 SER MET LEU SER PRO ASN PRO PRO ASN LEU THR LYS LYS SEQRES 2 B 121 MET LYS LYS ILE VAL ASP ALA VAL ILE LYS TYR LYS ASP SEQRES 3 B 121 SER SER SER GLY ARG GLN LEU SER GLU VAL PHE ILE GLN SEQRES 4 B 121 LEU PRO SER ARG LYS GLU LEU PRO GLU TYR TYR GLU LEU SEQRES 5 B 121 ILE ARG LYS PRO VAL ASP PHE LYS LYS ILE LYS GLU ARG SEQRES 6 B 121 ILE ARG ASN HIS LYS TYR ARG SER LEU ASN ASP LEU GLU SEQRES 7 B 121 LYS ASP VAL MET LEU LEU CYS GLN ASN ALA GLN THR PHE SEQRES 8 B 121 ASN LEU GLU GLY SER LEU ILE TYR GLU ASP SER ILE VAL SEQRES 9 B 121 LEU GLN SER VAL PHE THR SER VAL ARG GLN LYS ILE GLU SEQRES 10 B 121 LYS GLU ASP ASP HET FX5 A1601 20 HET EDO A1602 4 HET FX5 B1601 20 HET EDO B1602 4 HETNAM FX5 2-(6-AZANYL-5-PIPERAZIN-4-IUM-1-YL-PYRIDAZIN-3-YL) HETNAM 2 FX5 PHENOL HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 3 FX5 2(C14 H18 N5 O 1+) FORMUL 4 EDO 2(C2 H6 O2) FORMUL 7 HOH *266(H2 O) HELIX 1 AA1 PRO A 1455 TYR A 1472 1 18 HELIX 2 AA2 SER A 1482 ILE A 1486 5 5 HELIX 3 AA3 LEU A 1494 ILE A 1501 1 8 HELIX 4 AA4 ASP A 1506 ASN A 1516 1 11 HELIX 5 AA5 SER A 1521 ASN A 1540 1 20 HELIX 6 AA6 SER A 1544 LYS A 1566 1 23 HELIX 7 AA7 PRO B 1455 TYR B 1472 1 18 HELIX 8 AA8 SER B 1482 ILE B 1486 5 5 HELIX 9 AA9 LEU B 1494 ILE B 1501 1 8 HELIX 10 AB1 ASP B 1506 ASN B 1516 1 11 HELIX 11 AB2 SER B 1521 ASN B 1540 1 20 HELIX 12 AB3 SER B 1544 LYS B 1566 1 23 SITE 1 AC1 10 LEU A1451 VAL A1484 PHE A1485 LEU A1488 SITE 2 AC1 10 TYR A1497 VAL A1505 ALA A1536 PHE A1539 SITE 3 AC1 10 ASN A1540 ILE A1546 SITE 1 AC2 5 LYS A1511 ARG A1515 HOH A1742 HOH A1775 SITE 2 AC2 5 GLU B1542 SITE 1 AC3 11 LEU B1451 VAL B1484 PHE B1485 LEU B1488 SITE 2 AC3 11 TYR B1497 VAL B1505 ALA B1536 PHE B1539 SITE 3 AC3 11 ASN B1540 ILE B1546 HOH B1760 SITE 1 AC4 7 ARG A1515 GLN B1537 THR B1538 ASN B1540 SITE 2 AC4 7 LEU B1541 GLU B1542 HOH B1772 CRYST1 41.180 64.910 48.770 90.00 100.88 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024284 0.000000 0.004668 0.00000 SCALE2 0.000000 0.015406 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020880 0.00000